Pharmacal Health & Wellness Solutions - Chapter 11 Case Summary
Wisconsin Pharmacal Company (dba Pharmacal Health & Wellness Solutions) filed for Chapter 11 following a 2025 FDA warning letter that led to customer losses, mounting legal costs from a since-settled class action against subsidiary Lake Consumer Products, and First American Bank's refusal to extend its forbearance agreement, seeking to sell product lines to reduce or repay the bank's asserted $7.2 million claim, backed by a proposed DIP revolver of up to $1 million from Great Lakes Capital Solutions, controlled by minority indirect owners of the company's indirect parent.
Business Description
Jackson, Wisconsin-based Wisconsin Pharmacal Company, LLC ("WI Pharmacal") is the main operating company of a two-debtor group that includes its subsidiary Lake Consumer Products, Inc. ("Lake Consumer," and collectively with WI Pharmacal, the "Debtors"). WI Pharmacal manufactures or distributes over-the-counter drugs, health and wellness products, and outdoor products such as water purification products, insect repellents and citronella candles. Its main products are the MG217 brand of scalp and skin care products for symptoms of psoriasis, dandruff and other skin conditions; Potable Aqua tablets, used to purify water that may be unsafe to drink, such as while camping or hiking; and outdoor and safety products, including insect repellents, first aid products and outdoor accessories such as soap sheets.
Other brands include Sting-Eze insect bite relief products and Baitmate fish attractants, and WI Pharmacal is the licensee of Coleman insect repellents and Coleman first aid products. Beyond its branded portfolio, WI Pharmacal provides contract manufacturing and product formulation services for store-brand and private label consumer products. Customers are primarily large national retailers, and the Debtors generated approximately $23.7 million of gross revenue in the first ten months of 2026, through October 31.
Corporate History
WI Pharmacal was founded in Milwaukee in 1896 as a pharmacy co-op retailer. Lake Consumer acquired the MG217 line of psoriasis products around 2011, and WI Pharmacal acquired Lake Consumer sometime before 2020 to obtain the Yeast-Gard product, among other feminine healthcare products.
On July 13, 2020, Purity Acquisition Company ("Purity") acquired 100% of WPC Holdings, LLC ("WPC Holdings"), which owns 100% of WI Pharmacal; WI Pharmacal in turn owns 100% of Lake Consumer. Purity is indirectly owned by a group of investors that includes the two individuals who own Forge Capital Partners, LLC ("Forge") and who hold minority indirect stakes in Purity.
Operations Overview
WI Pharmacal manufactures most MG217 products, purchases the raw materials and pays the employees. The same management and officers control and operate both Debtors without a written agreement between them, and the Debtors report their finances jointly and file consolidated tax returns.
The Debtors operate from a 75,000-square-foot, FDA- and EPA-registered facility in Jackson, leased on a triple-net basis at approximately $42,000 per month from Monarch HoldCo, LLC ("Monarch"), whose principals are among the investors that indirectly own Purity. WI Pharmacal has approximately 44 full-time employees.
Walmart, Walgreens and CVS are all customers of the Debtors. Fourth-quarter revenue is historically low, as consumers buy fewer camping and outdoor products and shoppers at those retailers focus on holiday purchases rather than the Debtors' everyday products; revenue historically turns around beginning in February.
Prepetition Obligations
The Debtors' secured debt consists of two cross-collateralized facilities with First American Bank (the "Bank"), on which the Bank asserts $7,217,542 including costs and interest, and two subordinated secured loans from Forge. Trade accounts payable usually range from $2.5 million to $3.0 million.
First American Bank Facilities
On February 5, 2025, the Debtors refinanced their debt with the Bank under two facilities, each guaranteed solely by WPC Holdings:
- Revolving line of credit — $9 million, with draws governed by a borrowing base formula tied to the Debtors' accounts, receivables, inventory and work in process; approximately $5.1 million is outstanding. Excess availability is approximately $550,000, based on the most recent borrowing base calculation and a $250,000 over-advance the Bank provided under its forbearance agreement with the Debtors (the "Forbearance Agreement") as originally executed.
- Term note — $3 million, secured primarily by equipment; approximately $2.0 million is outstanding, although the balance appears as approximately $2.1 million in the First Day Declaration's cash collateral discussion.
On the same day as the refinancing, the Bank also lent money to Monarch, the Debtors' landlord; the leased premises are not collateral for the revolver or the term note.
Before the Petition Date, all receipts were deposited directly into the Debtors' account at the Bank, either electronically or through a Bank-controlled P.O. box. The Bank swept the account each day to pay down the revolver, leaving a zero balance, and lent funds back as the Debtors requested them.
Forge Loans
Forge is owed $250,000 plus accrued interest, secured by liens on all of the Debtors' assets that are subordinate to the Bank's lien. Forge separately lent $50,000, paid directly to Kerkman & Dunn to fund that firm's retainer and likewise secured by all of the Debtors' assets, subordinate to existing liens.
Cash Collateral Liens
According to the Debtors, the Bank and Forge are the only creditors with liens on the Debtors' accounts, receivables, inventory and work in process, and Citibank Europe PLC, listed as secured party on a financing statement originally dated in 2015, is owed nothing and has no interest in the Debtors' assets. The financing statement appears to perfect Citibank Europe's interest in amounts owed by the Debtors to SC Johnson, but the Debtors supply SC Johnson with products, so SC Johnson owes the Debtors rather than the reverse.
Asset Values
As of October 31, 2026, the book values were approximately $9.9 million for the Debtors' cash, accounts receivable, inventory and other current assets, approximately $3.0 million for machinery and equipment, and approximately $2.4 million for intangible assets (the product lines and a library of product formulations), with total book value of assets at $17 million. According to the First Day Declaration, the Debtors are worth $12 million to $17 million as a going concern, and the product lines are likely worth significantly more than book value because of their market recognition, their sales to large national retailers and goodwill, built over years of branded sales, that is not on the balance sheet.
The Debtors cite several reasons that liquidation value would be significantly lower if operations stopped:
- Brands and goodwill — National retailers would find alternatives, so potential buyers of the product lines would not have retailers in place, and the goodwill would eventually evaporate.
- Machinery and equipment — Sold piecemeal, the machinery and equipment would bring significantly less than book value.
- Receivables — Customers would likely claim setoffs against receivables because the Debtors would fail to honor contracts and purchase orders.
- Inventory — Most inventory is raw materials rather than finished goods, which would likely bring much less than cost.
Events Leading to Bankruptcy
FDA Warning Letter
The Debtors attribute the start of their distress to a surprise FDA inspection of their facilities in March 2025. A warning letter dated August 22, 2025 (the "Warning Letter") followed, finding alleged violations of, and alleged noncompliance with, certain federal regulations. According to the Debtors, the business generated meaningful positive adjusted EBITDA in each of the five years before the inspection, and although the Debtors acted immediately to correct the issues, the Warning Letter put operations into turmoil: the Debtors lost customers, other customers reduced purchases, and customers demanded greater oversight of the Debtors' manufacturing processes.
Maria C. Markusen joined both Debtors as President in July 2026 to improve operations and profitability, and since then the Debtors have reduced costs and addressed manufacturing quality issues. According to the Debtors, the issues raised in the Warning Letter have been resolved, although documentation still has to be completed on three items.
Lake Consumer Class Action
In September 2025, the U.S. District Court for the Eastern District of Pennsylvania denied in part Lake Consumer's motion to dismiss a class action filed earlier against it. The ruling allowed a complaint that had previously been dismissed to proceed and came after a new judge replaced the judge previously assigned to the case. According to the Debtors, the decision required Lake Consumer to begin spending substantial resources to defend the suit, prepare for discovery and take part in mediation. Lake Consumer has since settled the class action for $600,000, half as a cash payment to the class and half to the plaintiffs' lawyers.
Brand Sale Efforts and Forbearance
Legal fees mounted from defending the class action and responding to the Warning Letter. The Debtors tried to raise capital by selling certain brands and product lines, but according to the Debtors, the market showed little interest while the class action was pending and the Warning Letter was newly issued. In February 2026, the Debtors entered into the Forbearance Agreement with the Bank, which required Forge's $250,000 secured, subordinated loan as a condition.
Forbearance Expiration
Representatives of the Debtors had been in discussions with the Bank for several weeks when the parties met on Friday, November 13, 2026, two days before the Forbearance Agreement was due to expire on November 15. According to the Debtors, the Bank advised after the meeting that it would not extend the Forbearance Agreement and that, as of Monday, November 16, the Debtors would have no access to cash, and the Bank pressed for a Chapter 128 receivership to keep the business operating, along with a waiver of the Debtors' ability to file Chapter 11 petitions. The Debtors chose Chapter 11 to preserve going-concern value because, in their view, a receivership would pay only the Bank's claim. According to the Debtors, the Bank has still not permitted the Debtors to use cash, without which the Debtors cannot continue manufacturing or fund the next payroll.
Chapter 11 Filing
The Debtors are seeking emergency use of cash collateral and approval of DIP financing to make payroll, purchase materials and preserve going-concern value. At the same time, the Debtors are pursuing product line sales intended to reduce or repay the Bank's debt.
Cash Collateral
The Debtors would use cash collateral under a five-week budget of projected receipts and expenditures to pay employees, purchase materials and ship goods. The Debtors project operating losses on an accrual basis through December 2026, a seasonally low period. Receivables and inventory are currently at low levels and will require working capital as they increase. According to the Debtors, keeping the business running as a going concern is the best way for the Bank's collateral, including its intangible property, to hold its value.
DIP Financing
According to the Debtors, receivable collections may not cover operating needs in the near term, including working capital to manufacture products for the high sales months of February through September. The Debtors also have been unable to identify any financing on a strictly unsecured basis. The Debtors have obtained DIP financing from Great Lakes Capital Solutions, LLC ("Great Lakes"), which is controlled by minority indirect owners of Purity who also own Forge. The proposed terms are:
- Amount — Revolving line of credit of up to $1 million. Loans would be made only as needed, and principal would be repaid as the Debtors are able.
- Rate — Prime plus 5%, currently 12% per annum.
- Draw conditions — The Debtors would draw only to fund cash flow needs not met by receivable collections, and only where availability under the Bank's revolver is insufficient to fund budgeted expenses that must be paid to avoid immediate and irreparable harm.
- Liens — Great Lakes would receive liens on all assets, junior to the liens of the Bank and Forge, plus a first-priority lien on any assets in which neither the Bank nor Forge holds a lien.
- Priority — The DIP loan would have priority over all administrative expenses, subject to a $250,000 carve-out for professionals and U.S. Trustee fees.
Product Line Sales
In the week before the Petition Date, the Debtors received a signed letter of intent (the "LOI") from a prospective buyer to purchase one of their product lines for $2.3 million plus the value of the line's inventory. That product line generated approximately $2.1 million of gross revenue in 2025 and is expected to generate approximately $2.5 million to $2.7 million in 2026. The LOI contemplates that the Debtors would continue manufacturing the product on a contract basis. The Debtors have not countersigned the LOI because of the possible Chapter 11 filing. After the Debtors called the buyer to discuss their financial situation and that possible filing, the buyer stated that it wanted to move forward and close in 30 days.
According to the Debtors, closing the sale would significantly reduce the Bank's claim, a reduction that would likely not be available if the Debtors stopped operating. The Debtors also view the LOI as indicating that product lines whose intellectual property they own are worth approximately 1.0x gross annual revenue, potentially more. The Debtors' other owned product lines generated over $3.3 million of gross revenue and are expected to generate a similar or higher level in 2026, although the declaration dates both the historical figure and the projection to 2026.
Under their preliminary plan, the Debtors would finalize the LOI and close that sale while continuing to benefit from the contract manufacturing work. The Debtors also seek to sell one or more other product lines, which may result in the Bank being paid in full. The Debtors would likely then scale back operations and continue without bank debt, with the Bank either paid in full or its debt reduced by the product line sales.
Key Dates
- November 20, 2026 – According to the Debtors, the date by which they need access to cash to continue manufacturing
- November 24, 2026 – Payroll service draws funds for the next payroll
- November 25, 2026 – Next payroll date
- Mid-December 2026 – Lake Consumer's class action settlement payment due
First Day Motions
- Wages — WI Pharmacal seeks to pay prepetition wages through the next payroll, which covers the two weeks ending November 22, roughly half of it incurred prepetition. That payroll totals approximately $125,000, plus approximately $9,200 of employer Social Security and Medicare contributions and approximately $11,000 of 401(k) matching (up to 3% of pay). No employee is owed or will be paid more than $17,150, including benefits, and November health insurance premiums were paid prepetition. After this payroll, unused vacation and personal days would be the only amounts still owed for prepetition service. The payments would be funded from cash collateral and the DIP facility.
- Cash management — The Debtors seek to keep their prepetition account at the Bank, through which virtually all customer receipts and Debtor payments move electronically (43 of 44 employees are paid electronically). The Debtors cite the administrative burden that switching accounts would place on a staff already cut to the minimum, and the risk of delayed customer payments.